-+ 0.00%
-+ 0.00%
-+ 0.00%

TONIX PHARMACEUTICALS ANNOUNCES PRESENTATION OF PHASE 1 DATA AND OUTLINES PLANNED ADAPTIVE PHASE 2 FIELD STUDY OF TNX-4800 FOR THE PREVENTION OF LYME DISEASE, AT THE WORLD VACCINE CONGRESS WASHINGTON 2026

Reuters·03/31/2026 11:00:02

Please log in to view news